Palisade Bio, Inc. Announces Special Meeting of Stockholders to Vote on Reverse Stock Split
Ticker: PALI · Form: DEF 14A · Filed: Feb 6, 2024 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | DEF 14A |
| Filed Date | Feb 6, 2024 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: Reverse Stock Split, Special Meeting, Proxy Statement, Stockholder Vote, Corporate Governance
TL;DR
<b>Palisade Bio, Inc. is holding a virtual Special Meeting on March 25, 2024, to vote on a reverse stock split proposal.</b>
AI Summary
PALISADE BIO, INC. (PALI) filed a Proxy Statement (DEF 14A) with the SEC on February 6, 2024. Palisade Bio, Inc. will hold a Special Meeting of Stockholders on March 25, 2024, at 10:00 a.m. Pacific Time. The meeting will be conducted virtually via live webcast at www.proxydocs.com/PALI. Stockholders will vote on a proposal to amend the Company's Certificate of Incorporation to effect a reverse stock split. The reverse stock split ratio will be between 1-for-2 and 1-for-15, determined at the Board of Directors' discretion. A proposal to adjourn the meeting if necessary to solicit additional votes will also be presented.
Why It Matters
For investors and stakeholders tracking PALISADE BIO, INC., this filing contains several important signals. A reverse stock split is being proposed to potentially increase the stock price per share, which could make the stock more attractive to institutional investors and meet exchange listing requirements. The outcome of the reverse stock split vote is critical for the company's strategy to remain listed on major exchanges and improve its financial profile.
Risk Assessment
Risk Level: medium — PALISADE BIO, INC. shows moderate risk based on this filing. The company is seeking approval for a reverse stock split, indicating potential concerns about its current stock price and its ability to meet exchange listing requirements, which could lead to delisting if not addressed.
Analyst Insight
Stockholders should carefully consider the implications of the proposed reverse stock split on their investment and vote according to their best interests.
Key Numbers
- March 25, 2024 — Special Meeting Date (Date of Special Meeting of Stockholders)
- 10:00 a.m. Pacific Time — Special Meeting Time (Time of Special Meeting of Stockholders)
- 1-for-2 to 1-for-15 — Reverse Stock Split Ratio Range (Possible ratios for the reverse stock split)
- December 31, 2024 — Reverse Stock Split Deadline (Latest date for the reverse stock split to be effected)
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- March 25, 2024 (date) — Date of Special Meeting
- 10:00 a.m. Pacific Time (time) — Time of Special Meeting
- www.proxydocs.com/PALI (url) — Virtual Meeting Link
- 1-for-2 and 1-for-15 (ratio) — Range for reverse stock split
- December 31, 2024 (date) — Deadline for reverse stock split implementation
- Seneca Biopharma, Inc. (company) — Former Company Name
- Neuralstem, Inc. (company) — Former Company Name
Forward-Looking Statements
- The specific proposals for the Special Meeting will be disclosed in subsequent filings or proxy materials. (Palisade Bio, Inc.) — high confidence, target: Before March 25, 2024
FAQ
When did PALISADE BIO, INC. file this DEF 14A?
PALISADE BIO, INC. filed this Proxy Statement (DEF 14A) with the SEC on February 6, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by PALISADE BIO, INC. (PALI).
Where can I read the original DEF 14A filing from PALISADE BIO, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by PALISADE BIO, INC..
What are the key takeaways from PALISADE BIO, INC.'s DEF 14A?
PALISADE BIO, INC. filed this DEF 14A on February 6, 2024. Key takeaways: Palisade Bio, Inc. will hold a Special Meeting of Stockholders on March 25, 2024, at 10:00 a.m. Pacific Time.. The meeting will be conducted virtually via live webcast at www.proxydocs.com/PALI.. Stockholders will vote on a proposal to amend the Company's Certificate of Incorporation to effect a reverse stock split..
Is PALISADE BIO, INC. a risky investment based on this filing?
Based on this DEF 14A, PALISADE BIO, INC. presents a moderate-risk profile. The company is seeking approval for a reverse stock split, indicating potential concerns about its current stock price and its ability to meet exchange listing requirements, which could lead to delisting if not addressed.
What should investors do after reading PALISADE BIO, INC.'s DEF 14A?
Stockholders should carefully consider the implications of the proposed reverse stock split on their investment and vote according to their best interests. The overall sentiment from this filing is neutral.
Risk Factors
- Reverse Stock Split [medium — financial]: The company is proposing a reverse stock split to potentially increase its stock price per share, which may be necessary to maintain compliance with stock exchange listing requirements.
Key Dates
- 2024-03-25: Special Meeting of Stockholders — Vote on reverse stock split and adjournment proposal.
- 2024-12-31: Reverse Stock Split Effective Date Deadline — Latest date for the Board to implement the reverse stock split.
Glossary
- Reverse Stock Split
- A corporate action in which a company reduces the number of its outstanding shares by consolidating them into a smaller number. (Aims to increase the market price per share, potentially making the stock more attractive to investors and meeting exchange listing requirements.)
- Proxy Statement
- A document filed with the SEC that provides shareholders with information about matters to be voted on at a shareholder meeting. (Informs shareholders about the proposals, including the reverse stock split, and how to vote.)
Filing Stats: 4,836 words · 19 min read · ~16 pages · Grade level 11.9 · Accepted 2024-02-06 17:00:32
Filing Documents
- formdef14a.htm (DEF 14A) — 264KB
- formdef14a_001.jpg (GRAPHIC) — 5KB
- formpre14a_002.jpg (GRAPHIC) — 4KB
- proxy_001.jpg (GRAPHIC) — 196KB
- proxy_002.jpg (GRAPHIC) — 129KB
- 0001493152-24-005117.txt ( ) — 726KB
From the Filing
DEF 14A 1 formdef14a.htm UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy (Amendment No.__) Filed by the Registrant Filed by a party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under § 240.14a-12 PALISADE BIO, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box ): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 PALISADE BIO, INC. 7750 El Camino Real, Suite 2A Carlsbad, California 92009 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS To Be Held on March 25, 2024 Dear Stockholder: You are invited to attend a Special Meeting of Stockholders, or the “Special Meeting”, of Palisade Bio, Inc., a Delaware corporation, or the “Company”, to be held on Monday, March 25, 2024 at 10:00 a.m. Pacific Time. The Special Meeting will be held in a virtual meeting format only, via live webcast on the Internet, with no physical in-person meeting. You will be able to attend and participate in the Special Meeting online by visiting www.proxydocs.com/PALI , where you will be able to listen to the meeting live, submit questions and vote on the proposals. In order to join and participate in the virtual Special Meeting, you will need the 12-digit control number which is included in the Notice of Internet Availability of Proxy Materials, on your proxy card and on the instructions that accompanied the proxy materials you received. As always, we encourage you to vote your shares prior to the Special Meeting. You are being asked to vote on the following matters: 1. To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company’s Board of Directors: a reverse split of the Company’s common stock, at a ratio of not less than 1-for-2 and not greater than 1-for-15, with the exact ratio to be set within that range at the discretion of the Board of Directors, without further approval or authorization of our stockholders, and to be effected on or before December 31, 2024. We refer to this proposal as the “Reverse Stock Split Proposal” or “Proposal 1.” 2. To approve the adjournment of the Special Meeting, if necessary, to solicit additional votes and proxies if there are not sufficient votes in favor of the foregoing proposal. We refer to this as the “Adjournment Proposal” or “Proposal 2.” These items of business are more fully described in the proxy statement (“Proxy Statement”) accompanying this Notice. We have elected to provide electronic access to our proxy materials, which include the Notice of Special Meeting of Stockholders and Proxy to our stockholders the Notice of Internet Availability of Proxy Materials (the “Notice”) containing instructions on how to access our Proxy Materials. The Notice provides instructions on how to vote online or by telephone and how to receive a paper copy of the Proxy Materials by mail. Our Proxy Materials can be accessed on the Internet at: www.proxydocs.com/PALI using the control number located on your Notice, and also on your proxy card or voting instruction form, as applicable, if you have received printed proxy materials. The record date for the Special Meeting is February 2, 2024. Only stockholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. The Special Meeting will be conducted virtually. To participate, vote, or submit questions during the Special Meeting via live webcast, please visit www.proxydocs.com/PALI . You will not be able to attend the Special Meeting in person. By Order of the Board of Directors /s/ James R. Neal James R. Neal Chairman February 6, 2024 You are cordially invited to attend the virtual Special Meeting. Whether or not you expect to attend the Special Meeting virtually, PLEASE VOTE YOUR SHARES. As an alternative to voting online at the Special Meeting, you may vote via the internet, by telephone or, if you receive a paper proxy card by mailing the completed proxy card. Voting instructions are provided in the instructions printed on your proxy card. Even if you have voted by proxy, you may still vote online at the Special Meeting. Please note, however, that if your shares are held of record by a broker, bank or other agent and you wish to vote at the Special Meeting, you must follow the instructions from such organization and will need to obtain a proxy issued in your name from that record holder. PALISA